Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 4/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.36 |
| ▸ | PAM | P19021 | 2/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | CASP2 | P42575 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13616524 | 1.00 | DGKA (0.39) | DGKACA12CA2CA7CA9 | |
| SCHEMBL13616521 | 0.88 | DGKA (0.51) | DGKAL3MBTL1PAMALDH1A1TSHR | |
| SCHEMBL17779433 | 0.88 | LTA4H (0.39) | DGKACA12CA2CA7CA9 | |
| SCHEMBL13616529 | 0.82 | DGKA (0.49) | DGKACA12CA2CA7CA9 | |
| SCHEMBL13616503 | 0.81 | ALDH1A1 (0.35) | LTA4HALDH1A1GAA | |
| SCHEMBL16232292 | 0.79 | CYP1A2 (0.42) | CA12CA2CA7CA9CA14 | |
| SCHEMBL9761793 | 0.78 | DGKA (0.62) | DGKAPAMALDH1A1TSHR | |
| SCHEMBL15024334 | 0.78 | DGKA (0.62) | DGKAPAMALDH1A1TSHR | |
| SCHEMBL17812601 | 0.78 | DGKA (0.62) | DGKAPAMALDH1A1TSHR | |
| SCHEMBL3412329 | 0.78 | DGKA (0.62) | DGKAPAMALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009138341-A2 | POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS | BASF SE (DE) | 2009-11-19 | — | — | WO | disclosed |
| US-20090286878-A1 | POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS | CIBA CORP. | 2009-11-19 | — | — | US | disclosed |
| US-20090286878-A1 | POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS | CIBA CORP. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286878-A1 | POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS | CUTA, PHOSPHO1, DPM1 | DGKA 467/4885CA12 1433/4885CA2 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.